Related Experiment Video
Updated: Jun 1, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Tertiary hyperparathyroidism resistant to cinacalcet treatment
Manabu Okada1, Yoshihiro Tominaga, Kumiko Izumi
1Department of Transplantation and Endocrine Surgery, Nagoya Second Red Cross Hospital, Showa-ku, Nagoya, Japan.
Cinacalcet resistance in tertiary hyperparathyroidism may be linked to enlarged parathyroid glands. Severely enlarged nodular glands appear to be a key factor in treatment non-response.
Area of Science:
- Nephrology
- Endocrinology
- Surgical Pathology
Background:
- Tertiary hyperparathyroidism (THPT) is a common complication in patients with chronic kidney disease.
- Cinacalcet hydrochloride (cinacalcet) is a calcimimetic agent used to manage THPT.
- Treatment resistance to cinacalcet necessitates alternative therapeutic strategies, such as parathyroidectomy (PTx).
Purpose of the Study:
- To investigate the clinical characteristics and course of patients with THPT resistant to cinacalcet treatment.
- To identify potential factors contributing to cinacalcet resistance in THPT patients.
Main Methods:
- Retrospective analysis of five THPT patients who underwent PTx due to cinacalcet resistance.
- Evaluation of parathyroid gland size via ultrasonography prior to renal transplantation.
- Monitoring of serum calcium, phosphorus, intact parathyroid hormone (iPTH), alkaline phosphatase (ALP), and creatinine (Cr) levels before and after cinacalcet administration and PTx.
Main Results:
- All five patients exhibited at least one parathyroid gland with a maximum diameter exceeding 1 cm (mean diameter: 18.7 mm).
- Serum iPTH and ALP levels showed a gradual increase following cinacalcet initiation.
- Post-PTx, transient increases in Cr levels were observed.
Conclusions:
- Severely enlarged nodular hyperplastic parathyroid glands appear to be a significant factor contributing to cinacalcet resistance in THPT.
- Parathyroid gland size may predict treatment response to cinacalcet in THPT patients.
- Further research is warranted to explore the relationship between gland morphology and calcimimetic efficacy.
Related Concept Videos
Urinary Tract Calculi III: Medical Management
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Chronic Kidney Disease III: Interprofessional Care
Tertiary Healthcare System
Treatment Resistent Cancers
